Ten years ago April marks the anniversary of the first time I wrote about low-dose naltrexone (LDN). I described it as an orphan drug, meaning that its patent had long ago expired, that it was generic, and that it was not owned by any one company. For these reasons and because they’d never recoup their investment, no Big Pharma company was interested in pursuing the Read More
- About WHC
- Resources
- Education
- Health Tips
- Knowledge Base
- Acupuncture/Traditional Chinese Medicine
- Aging
- Allergies & Food Sensitivities
- Alternative Therapies
- Big Pharma Evils
- Bone Health
- Candida (yeast) and Parasites
- Cardiovascular Health
- Case Studies
- Chiropractic & Physical Medicine
- Dermatology
- Digestion
- Diseases
- Ear, Nose, & Throat
- Environmental Sensitivities
- Eye Care
- Fibromyalgia & Chronic Fatigue
- Fitness & Exercise
- Health Insurance Issues
- Healthy Lifestyle
- Immune System
- Inflammation
- Integrative Medicine
- Lyme Disease & Morgellons
- Men’s Health
- Mental Health
- Nutrition, Nutritional Supplements, Vitamins, & Herbal Remedies
- Pain Management
- Sexual Health
- Thyroid, Adrenal, & Sex Hormone Issues
- Weight Issues
- Women’s Health
- Continuing Professional Education
- Workshops
- Apothecary
- Contact WHC
- Our Practitioners